Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from peripheral academic research consortium (PARC)

Manesh R. Patel, Michael S. Conte, Donald E. Cutlip, Nabil Dib, Patrick Geraghty, William Gray, William R. Hiatt, Mami Ho, Koji Ikeda, Fumiaki Ikeno, Michael R. Jaff, W. Schuyler Jones, Masayuki Kawahara, Robert A. Lookstein, Roxana Mehran, Sanjay Misra, Lars Norgren, Jeffrey W. Olin, Thomas J. Povsic, Kenneth RosenfieldJohn Rundback, Fadi Shamoun, James Tcheng, Thomas T. Tsai, Yuka Suzuki, Pascal Vranckx, Bret N. Wiechmann, Christopher J. White, Hiroyoshi Yokoi, Mitchell W. Krucoff

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

The lack of consistent definitions and nomenclature across clinical trials of novel devices, drugs, or biologics poses a significant barrier to accrual of knowledge in and across peripheral artery disease therapies and technologies. Recognizing this problem, the Peripheral Academic Research Consortium, together with the U.S. Food and Drug Administration and the Japanese Pharmaceuticals and Medical Devices Agency, has developed a series of pragmatic consensus definitions for patients being treated for peripheral artery disease affecting the lower extremities. These consensus definitions include the clinical presentation, anatomic depiction, interventional outcomes, surrogate imaging and physiological follow-up, and clinical outcomes of patients with lower-extremity peripheral artery disease. Consistent application of these definitions in clinical trials evaluating novel revascularization technologies should result in more efficient regulatory evaluation and best practice guidelines to inform clinical decisions in patients with lower extremity peripheral artery disease.

Original languageEnglish (US)
Pages (from-to)931-941
Number of pages11
JournalJournal of the American College of Cardiology
Volume65
Issue number9
DOIs
StatePublished - Mar 10 2015

Fingerprint

Peripheral Arterial Disease
Lower Extremity
Practice Guidelines
Research
Clinical Trials
Technology
Equipment and Supplies
United States Food and Drug Administration
Therapeutics
Biological Products
Terminology
Pharmaceutical Preparations

Keywords

  • amputation
  • foot
  • intermittent claudication
  • leg
  • myocardial infarction
  • stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Evaluation and treatment of patients with lower extremity peripheral artery disease : Consensus definitions from peripheral academic research consortium (PARC). / Patel, Manesh R.; Conte, Michael S.; Cutlip, Donald E.; Dib, Nabil; Geraghty, Patrick; Gray, William; Hiatt, William R.; Ho, Mami; Ikeda, Koji; Ikeno, Fumiaki; Jaff, Michael R.; Jones, W. Schuyler; Kawahara, Masayuki; Lookstein, Robert A.; Mehran, Roxana; Misra, Sanjay; Norgren, Lars; Olin, Jeffrey W.; Povsic, Thomas J.; Rosenfield, Kenneth; Rundback, John; Shamoun, Fadi; Tcheng, James; Tsai, Thomas T.; Suzuki, Yuka; Vranckx, Pascal; Wiechmann, Bret N.; White, Christopher J.; Yokoi, Hiroyoshi; Krucoff, Mitchell W.

In: Journal of the American College of Cardiology, Vol. 65, No. 9, 10.03.2015, p. 931-941.

Research output: Contribution to journalArticle

Patel, MR, Conte, MS, Cutlip, DE, Dib, N, Geraghty, P, Gray, W, Hiatt, WR, Ho, M, Ikeda, K, Ikeno, F, Jaff, MR, Jones, WS, Kawahara, M, Lookstein, RA, Mehran, R, Misra, S, Norgren, L, Olin, JW, Povsic, TJ, Rosenfield, K, Rundback, J, Shamoun, F, Tcheng, J, Tsai, TT, Suzuki, Y, Vranckx, P, Wiechmann, BN, White, CJ, Yokoi, H & Krucoff, MW 2015, 'Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from peripheral academic research consortium (PARC)', Journal of the American College of Cardiology, vol. 65, no. 9, pp. 931-941. https://doi.org/10.1016/j.jacc.2014.12.036
Patel, Manesh R. ; Conte, Michael S. ; Cutlip, Donald E. ; Dib, Nabil ; Geraghty, Patrick ; Gray, William ; Hiatt, William R. ; Ho, Mami ; Ikeda, Koji ; Ikeno, Fumiaki ; Jaff, Michael R. ; Jones, W. Schuyler ; Kawahara, Masayuki ; Lookstein, Robert A. ; Mehran, Roxana ; Misra, Sanjay ; Norgren, Lars ; Olin, Jeffrey W. ; Povsic, Thomas J. ; Rosenfield, Kenneth ; Rundback, John ; Shamoun, Fadi ; Tcheng, James ; Tsai, Thomas T. ; Suzuki, Yuka ; Vranckx, Pascal ; Wiechmann, Bret N. ; White, Christopher J. ; Yokoi, Hiroyoshi ; Krucoff, Mitchell W. / Evaluation and treatment of patients with lower extremity peripheral artery disease : Consensus definitions from peripheral academic research consortium (PARC). In: Journal of the American College of Cardiology. 2015 ; Vol. 65, No. 9. pp. 931-941.
@article{fdd3ff5fe49d468b8336f65e21ce3c2f,
title = "Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from peripheral academic research consortium (PARC)",
abstract = "The lack of consistent definitions and nomenclature across clinical trials of novel devices, drugs, or biologics poses a significant barrier to accrual of knowledge in and across peripheral artery disease therapies and technologies. Recognizing this problem, the Peripheral Academic Research Consortium, together with the U.S. Food and Drug Administration and the Japanese Pharmaceuticals and Medical Devices Agency, has developed a series of pragmatic consensus definitions for patients being treated for peripheral artery disease affecting the lower extremities. These consensus definitions include the clinical presentation, anatomic depiction, interventional outcomes, surrogate imaging and physiological follow-up, and clinical outcomes of patients with lower-extremity peripheral artery disease. Consistent application of these definitions in clinical trials evaluating novel revascularization technologies should result in more efficient regulatory evaluation and best practice guidelines to inform clinical decisions in patients with lower extremity peripheral artery disease.",
keywords = "amputation, foot, intermittent claudication, leg, myocardial infarction, stroke",
author = "Patel, {Manesh R.} and Conte, {Michael S.} and Cutlip, {Donald E.} and Nabil Dib and Patrick Geraghty and William Gray and Hiatt, {William R.} and Mami Ho and Koji Ikeda and Fumiaki Ikeno and Jaff, {Michael R.} and Jones, {W. Schuyler} and Masayuki Kawahara and Lookstein, {Robert A.} and Roxana Mehran and Sanjay Misra and Lars Norgren and Olin, {Jeffrey W.} and Povsic, {Thomas J.} and Kenneth Rosenfield and John Rundback and Fadi Shamoun and James Tcheng and Tsai, {Thomas T.} and Yuka Suzuki and Pascal Vranckx and Wiechmann, {Bret N.} and White, {Christopher J.} and Hiroyoshi Yokoi and Krucoff, {Mitchell W.}",
year = "2015",
month = "3",
day = "10",
doi = "10.1016/j.jacc.2014.12.036",
language = "English (US)",
volume = "65",
pages = "931--941",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Evaluation and treatment of patients with lower extremity peripheral artery disease

T2 - Consensus definitions from peripheral academic research consortium (PARC)

AU - Patel, Manesh R.

AU - Conte, Michael S.

AU - Cutlip, Donald E.

AU - Dib, Nabil

AU - Geraghty, Patrick

AU - Gray, William

AU - Hiatt, William R.

AU - Ho, Mami

AU - Ikeda, Koji

AU - Ikeno, Fumiaki

AU - Jaff, Michael R.

AU - Jones, W. Schuyler

AU - Kawahara, Masayuki

AU - Lookstein, Robert A.

AU - Mehran, Roxana

AU - Misra, Sanjay

AU - Norgren, Lars

AU - Olin, Jeffrey W.

AU - Povsic, Thomas J.

AU - Rosenfield, Kenneth

AU - Rundback, John

AU - Shamoun, Fadi

AU - Tcheng, James

AU - Tsai, Thomas T.

AU - Suzuki, Yuka

AU - Vranckx, Pascal

AU - Wiechmann, Bret N.

AU - White, Christopher J.

AU - Yokoi, Hiroyoshi

AU - Krucoff, Mitchell W.

PY - 2015/3/10

Y1 - 2015/3/10

N2 - The lack of consistent definitions and nomenclature across clinical trials of novel devices, drugs, or biologics poses a significant barrier to accrual of knowledge in and across peripheral artery disease therapies and technologies. Recognizing this problem, the Peripheral Academic Research Consortium, together with the U.S. Food and Drug Administration and the Japanese Pharmaceuticals and Medical Devices Agency, has developed a series of pragmatic consensus definitions for patients being treated for peripheral artery disease affecting the lower extremities. These consensus definitions include the clinical presentation, anatomic depiction, interventional outcomes, surrogate imaging and physiological follow-up, and clinical outcomes of patients with lower-extremity peripheral artery disease. Consistent application of these definitions in clinical trials evaluating novel revascularization technologies should result in more efficient regulatory evaluation and best practice guidelines to inform clinical decisions in patients with lower extremity peripheral artery disease.

AB - The lack of consistent definitions and nomenclature across clinical trials of novel devices, drugs, or biologics poses a significant barrier to accrual of knowledge in and across peripheral artery disease therapies and technologies. Recognizing this problem, the Peripheral Academic Research Consortium, together with the U.S. Food and Drug Administration and the Japanese Pharmaceuticals and Medical Devices Agency, has developed a series of pragmatic consensus definitions for patients being treated for peripheral artery disease affecting the lower extremities. These consensus definitions include the clinical presentation, anatomic depiction, interventional outcomes, surrogate imaging and physiological follow-up, and clinical outcomes of patients with lower-extremity peripheral artery disease. Consistent application of these definitions in clinical trials evaluating novel revascularization technologies should result in more efficient regulatory evaluation and best practice guidelines to inform clinical decisions in patients with lower extremity peripheral artery disease.

KW - amputation

KW - foot

KW - intermittent claudication

KW - leg

KW - myocardial infarction

KW - stroke

UR - http://www.scopus.com/inward/record.url?scp=84924690336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924690336&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2014.12.036

DO - 10.1016/j.jacc.2014.12.036

M3 - Article

C2 - 25744011

AN - SCOPUS:84924690336

VL - 65

SP - 931

EP - 941

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 9

ER -